Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

2.9K
Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
2.9K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.6K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Design and synthesis of quinazoline derivatives as novel JMJD3/HDAC dual-target inhibitors.

RSC medicinal chemistry·2026
Same author

Discovery of pyrrolo[2,3-d]pyrimidine derivatives with inhibitory effect on liver cancer stem cell.

Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents·2026
Same author

Discovery of quinazoline-based derivatives as novel autophagy inhibitors in pancreatic cancer.

Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents·2026
Same author

A Gradient-Guided Spatio-Temporal Graph Convolutional Network for Population-Level Major Depressive Disorder Classification.

IEEE journal of biomedical and health informatics·2026
Same author

Discovery of a novel CaMKⅡα inhibitor by machine learning, molecular docking and molecular dynamics simulation.

Journal of computer-aided molecular design·2026
Same author

Multicharged Foldable Plasma Membrane Probes for Precise Cancer Cell Discrimination and Fluorescence-Guided Surgery.

Analytical chemistry·2026

Related Experiment Video

Updated: May 17, 2025

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

27.1K

Precise Electromagnetic Modulation of the Cell Cycle and Its Applications in Cancer Therapy.

Keni Shi1,2, Xiqing Peng1,2, Ting Xu1,2

  • 1School of Biomedical Engineering, Sun Yat-sen University, No. 135, Xingang Xi Road, Guangzhou 510275, China.

International Journal of Molecular Sciences
|May 14, 2025
PubMed
Summary

Electromagnetic (EM) modulation precisely controls the cell cycle for advanced cancer therapy. This technology integrates with AI, immunotherapy, and nanotechnology to enhance treatment efficacy and overcome tumor complexities.

Keywords:
cancer therapycell cycle controlelectromagnetic modulationpersonalized treatmenttumor microenvironment

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.5K
Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

11.0K

Related Experiment Videos

Last Updated: May 17, 2025

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

27.1K
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.5K
Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

11.0K

Area of Science:

  • Oncology
  • Biophysics
  • Biotechnology

Background:

  • Precise cell cycle control is crucial for effective cancer therapy.
  • Electromagnetic (EM) fields offer a non-invasive method to modulate cellular processes.
  • Personalized cancer treatment strategies require novel therapeutic approaches.

Purpose of the Study:

  • To review the mechanisms of EM field influence on cancer cell dynamics.
  • To highlight advancements in EM modulation platforms for cell cycle regulation.
  • To explore the integration of EM modulation with emerging technologies for enhanced cancer treatment.

Main Methods:

  • Review of existing literature on EM modulation in cancer therapy.
  • Analysis of mechanisms by which EM fields regulate proliferation, apoptosis, and repair.
  • Systematic analysis of clinical studies on EM modulation technology.

Main Results:

  • EM fields precisely regulate cancer cell proliferation, apoptosis, and repair.
  • High-throughput EM modulation platforms enable precise cell cycle control.
  • Integration with AI, immunotherapy, and nanotechnology enhances targeting and efficacy.
  • EM modulation overcomes challenges like tumor heterogeneity and microenvironment complexity.

Conclusions:

  • EM modulation shows significant potential for individualized and multimodal cancer treatment.
  • Further research is needed for clinical translation and optimization of EM-based therapies.
  • EM modulation can be a core component of future precision oncology strategies.